The National Academies of Sciences, Engineering, and Medicine Committee on Evidence-based Clinical Practice Guidelines for Prescribing Opioids for Acute Pain will host a Feb. 4 public workshop as part of its information gathering activities. The Food and Drug Administration last year awarded NASEM a contract to develop evidence-based guidelines for appropriate opioid prescribing for acute pain. The workshop will feature presentations and panel discussions on surgical procedures and medical conditions associated with acute pain, and identifying and using evidence to inform the guidelines. To attend the workshop in person or via webcast, register here. AHA is a member of the National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic, a public-private partnership that will develop and disseminate evidence-based solutions to reduce opioid misuse and improve outcomes for individuals, families and communities affected by addiction.
 

Related News Articles

Headline
The National Academies of Sciences Engineering, and Medicine yesterday released recommendations for improving outcomes and metrics associated with four grant…
Headline
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM)…
Headline
Mallinckrodt Pharmaceuticals today announced an agreement in principle on a settlement to resolve all opioid-related claims against the company in…
Headline
Public and private entities can apply for $1 million grants for a three-year period to enhance or expand opioid and other substance use disorder services in…
Headline
Rep. Vicky Hartzler, R-Mo., House Energy and Commerce Committee Ranking Member Greg Walden, R-Ore., and other Republicans on the committee last week asked the…
Headline
The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing to highlight how federal funds have helped states combat…